Literature DB >> 24853610

Tobacco smoke exposure in pulmonary arterial and thromboembolic pulmonary hypertension.

Stephan Keusch1, Florian F Hildenbrand, Tom Bollmann, Michael Halank, Matthias Held, Ralf Kaiser, Gabor Kovacs, Tobias J Lange, Hans-Jürgen Seyfarth, Rudolf Speich, Silvia Ulrich.   

Abstract

BACKGROUND: Animal studies and data from a single-center study suggest that tobacco smoke exposure may be a risk factor for precapillary pulmonary hypertension (PH).
OBJECTIVE: We aimed to survey tobacco smoke exposure in a large PH collective and to compare it with epidemiological data from healthy subjects.
METHODS: This is an international, multicenter, case-control study including patients with pulmonary arterial and chronic thromboembolic PH. All patients were asked specific questions about tobacco smoke exposure. Healthy controls were retrieved from the Swiss Health Survey (n = 18,747).
RESULTS: Overall (n = 472), 49% of PH patients were smokers and there was a clear sex difference (women 37%, men 71%). Significantly more PH men were smokers compared with healthy controls, whereas less PH women were ever active smokers. However, 50% of the non-smoking PH women were exposed to secondhand smoke, leading to a significantly higher number of tobacco smoke-exposed individuals compared to healthy controls. PH smokers were significantly younger compared to those not exposed.
CONCLUSION: Active and environmental tobacco smoke exposure is common in PH. The higher prevalence of male PH smokers, the higher exposure to environmental tobacco smoke in PH women compared to healthy controls and the lower age at PH diagnosis in smokers may indicate a pathogenic role of tobacco smoke exposure in PH.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24853610     DOI: 10.1159/000359972

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  12 in total

Review 1.  The role of genetics in pulmonary arterial hypertension.

Authors:  Lijiang Ma; Wendy K Chung
Journal:  J Pathol       Date:  2016-11-29       Impact factor: 7.996

2.  Drug-induced pulmonary arterial hypertension: a primer for clinicians and scientists.

Authors:  Mark E Orcholski; Ke Yuan; Charlotte Rajasingh; Halley Tsai; Elya A Shamskhou; Navneet K Dhillon; Norbert F Voelkel; Roham T Zamanian; Vinicio A de Jesus Perez
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-02-08       Impact factor: 5.464

3.  Bosentan or Macitentan Therapy in Chronic Thromboembolic Pulmonary Hypertension?

Authors:  M C J van Thor; L Ten Klooster; R J Snijder; J C Kelder; J J Mager; M C Post
Journal:  Lung       Date:  2019-10-03       Impact factor: 2.584

4.  Angiotensin II type 1 receptor mediates pulmonary hypertension and right ventricular remodeling induced by inhaled nicotine.

Authors:  Nicholas D Fried; Tamara M Morris; Anna Whitehead; Eric Lazartigues; Xinping Yue; Jason D Gardner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-02-12       Impact factor: 4.733

5.  Environmental tobacco smoke increases autophagic effects but decreases longevity associated with Sirt-1 protein expression in young C57BL mice hearts.

Authors:  Wei-Jen Ting; Jaw-Ji Yang; Chia-Hua Kuo; Zi-Jun Xiao; Xin-Ze Lu; Yu-Lan Yeh; Cecilia-Hsuan Day; Su-Ying Wen; Vijaya PadmaViswanadha; Chong-He Jiang; Wei-Wen Kuo; Chih-Yang Huang
Journal:  Oncotarget       Date:  2016-06-28

6.  Serum-Free Thyroxine Levels Were Associated with Pulmonary Hypertension and Pulmonary Artery Systolic Pressure in Euthyroid Patients with Coronary Artery Disease.

Authors:  Bingjie Wu; Jingjing Jiang; Minghui Gui; Lin Liu; Qiqige Aleteng; Shanshan Wang; Xiaojing Liu; Yan Ling; Xin Gao
Journal:  Int J Endocrinol       Date:  2017-06-22       Impact factor: 3.257

7.  Fractionated Concurrent Exercise throughout the Day Does Not Promote Acute Blood Pressure Benefits in Hypertensive Middle-aged Women.

Authors:  Luan M Azevêdo; Alice C de Souza; Laiza Ellen S Santos; Rodrigo Miguel Dos Santos; Manuella O M de Fernandes; Jeeser A Almeida; Emerson Pardono
Journal:  Front Cardiovasc Med       Date:  2017-02-14

Review 8.  Chronic Obstructive Pulmonary Disease and the Cardiovascular System: Vascular Repair and Regeneration as a Therapeutic Target.

Authors:  Srikanth Karnati; Michael Seimetz; Florian Kleefeldt; Avinash Sonawane; Thati Madhusudhan; Akash Bachhuka; Djuro Kosanovic; Norbert Weissmann; Karsten Krüger; Süleyman Ergün
Journal:  Front Cardiovasc Med       Date:  2021-04-12

9.  A Novel Tobacco Use Phenotype Suggests the 15q25 and 19q13 Loci May be Differentially Associated With Cigarettes per Day and Tobacco-Related Problems.

Authors:  Leah S Richmond-Rakerd; Jacqueline M Otto; Wendy S Slutske; Cindy L Ehlers; Kirk C Wilhelmsen; Ian R Gizer
Journal:  Nicotine Tob Res       Date:  2017-04-01       Impact factor: 4.244

10.  Knocking Out Smoking and Pulmonary Hypertension with a K.

Authors:  Steven K Huang
Journal:  Am J Respir Crit Care Med       Date:  2021-05-15       Impact factor: 30.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.